Zonegran

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 59212-680
  • Package NDC 59212-680-10
  • Application number NDA020789
  • SPL ID 66904ccc-bcd1-427c-95ed-bfa633bbf0b2
  • SPL set ID d12de43e-3ac3-4335-bc85-70d7366a91eb
  • UNII 459384H98V
  • RxCUI 284408
  • RxCUI 314285
  • RxCUI 403966
  • RxCUI 404725

What the source publishes

Labeler
Advanz Pharma (US) Corp.
Active ingredients
Zonisamide
Form
CAPSULE
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
NDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:59212-680_66904ccc-bcd1-427c-95ed-bfa633bbf0b2
{
  "name": "Zonegran",
  "splId": "66904ccc-bcd1-427c-95ed-bfa633bbf0b2",
  "labels": [
    {
      "setId": "d12de43e-3ac3-4335-bc85-70d7366a91eb",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d12de43e-3ac3-4335-bc85-70d7366a91eb",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d12de43e-3ac3-4335-bc85-70d7366a91eb"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "Advanz Pharma (US) Corp.",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "100 CAPSULE in 1 BOTTLE (59212-680-10)",
      "package_ndc": "59212-680-10",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20000327"
    }
  ],
  "productId": "59212-680_66904ccc-bcd1-427c-95ed-bfa633bbf0b2",
  "useDomain": "unknown",
  "dosageForm": "CAPSULE",
  "productNdc": "59212-680",
  "deaSchedule": null,
  "genericName": "Zonisamide",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "ZONISAMIDE",
      "strength": "100 mg/1"
    }
  ],
  "applicationNumber": "NDA020789",
  "marketingCategory": "NDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20000327",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000175753",
      "N0000008486",
      "M0020790",
      "N0000000235",
      "N0000185503"
    ],
    "upc": [
      "0359212680105"
    ],
    "unii": [
      "459384H98V"
    ],
    "rxcui": [
      "284408",
      "314285",
      "403966",
      "404725"
    ],
    "spl_set_id": [
      "d12de43e-3ac3-4335-bc85-70d7366a91eb"
    ],
    "pharm_class_cs": [
      "Sulfonamides [CS]"
    ],
    "pharm_class_pe": [
      "Decreased Central Nervous System Disorganized Electrical Activity [PE]"
    ],
    "pharm_class_epc": [
      "Anti-epileptic Agent [EPC]"
    ],
    "pharm_class_moa": [
      "Carbonic Anhydrase Inhibitors [MoA]",
      "P-Glycoprotein Inhibitors [MoA]"
    ],
    "manufacturer_name": [
      "Advanz Pharma (US) Corp."
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:59212-680_66904ccc-bcd1-427c-95ed-bfa633bbf0b2"